Drug resistance is a common cause of treatment failure in cancer therapy, and molecular
mechanisms need further exploration. Competing endogenous RNAs (ceRNAs) can …

Cancer is still a major health problem around the world. The treatment failure of cancer has
largely been attributed to drug resistance. Competitive endogenous RNAs (ceRNAs) are …

Non-coding RNAs (ncRNAs) have been implicated in most cellular functions. The disruption
of their function through somatic mutations, genomic imprinting, transcriptional and post …

Chemotherapy is often the primary and most effective anticancer treatment; however, drug
resistance remains a major obstacle to it being curative. Recent studies have demonstrated …

Long non‐coding RNAs (lncRNAs), a class of long RNAs, are longer than 200 nucleotides in
length but lack protein‐coding capacity. LncRNAs, as critical genomic regulators, are …

Chemoresistance including intrinsic and acquired anticancer drug resistance continues to
be a primary hindrance towards curative cancer treatment. Therefore, deciphering the …

Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a
serious, long-term threat to patients' health and life. Systemic chemotherapy remains the first …

Chemotherapy is one of the basic treatments for cancers; however, drug resistance is mainly
responsible for the failure of clinical treatment. The mechanism of drug resistance is …

The presence or emergence of chemoresistance in tumor cells is a major burden in cancer
therapy. While drug resistance is a multifactorial phenomenon arising from altered …

Background Malignant tumors have become the most dangerous disease in recent years.
Chemotherapy is the most effective treatment for this disease; however, the problem of drug …